Swedencare just reported Q3 2026, and the story is simple. The pet health specialist delivered its strongest quarter of the year in both sales and profitability, yet the share price closed at SEK18.8 after a run of weak recent returns, down about 18% over 7 days and 12% over 30 days. That disconnect puts the spotlight on one thing: earnings power. Revenue reached SEK737.9m with basic earnings per share of SEK0.18, and the debate now is whether that improving profit trend justifies a market that still treats the stock with caution.

Love Swedencare’s improving earnings profile but concerned that recent share price weakness signals too much risk in a single stock? Look at our 229 resilient stocks with low risk scores to benchmark this Q3…